Evidences for a direct action in striatum of dopaminergic receptor antagonists mediating DOPAC formation.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000096:biosynthesis*; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D010095:Oxotremorine / Q000494:pharmacology; D010648:Phenylacetates / Q000096:biosynthesis*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D014268:Trifluoperazine / Q000494:pharmacology
D010648:Phenylacetates; D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D014268:Trifluoperazine; D010095:Oxotremorine; D006220:Haloperidol